| Income Tax Disclosure [Abstract] | Period [Axis] |
|---|
2016-01-01 - 2016-12-31 |
|---|
Income Tax Disclosure [Abstract] | |
Information About Domestic And Foreign Pre-Tax Income | The components of income tax expense for the years ended December 31 were as follows:
| | | | | | | | | | | | | | Years Ended December 31, | | 2016 | | 2015 | | 2014 | Pre-tax income: | | | | | | Domestic | $ | 778,989 |
| | $ | 126,797 |
| | $ | 632,738 |
| Foreign | 69,599 |
| | 74,384 |
| | 111,399 |
| Total pre-tax income | $ | 848,588 |
| | $ | 201,181 |
| | $ | 744,137 |
|
|
Components Of Income Tax Expense (Benefit) | | | | | | | | | | | | | | | Years Ended December 31, | | 2016 | | 2015 | | 2014 | Current expense: | | | | | | Federal and state | $ | 240,125 |
| | $ | 40,643 |
| | $ | 162,483 |
| Foreign | 18,105 |
| | 22,851 |
| | 46,593 |
| Total current expense | 258,230 |
| | 63,494 |
| | 209,076 |
| Deferred expense (benefit): | | | | | | Federal and state | 19,558 |
| | 173 |
| | 72,645 |
| Foreign | 5,450 |
| | (4,041 | ) | | (8,491 | ) | Total deferred expense (benefit) | 25,008 |
| | (3,868 | ) | | 64,154 |
| Total income tax expense | $ | 283,238 |
| | $ | 59,626 |
| | $ | 273,230 |
|
|
Reconciliation Of Federal Income Tax Rate | A reconciliation of the federal income tax rate to the Company’s effective income tax rate follows: | | | | | | | | | | | December 31, | | 2016 | | 2015 | | 2014 | Federal income tax rate: | 35.0 | % | | 35.0 | % | | 35.0 | % | Reconciling items: | | | | | | Non-taxable investment income | (1.3 | ) | | (6.8 | ) | | (1.9 | ) | Foreign earnings (a) | (1.9 | ) | | (5.2 | ) | | (2.2 | ) | Non deductible compensation
| (0.1 | ) | | 9.1 |
| | 3.8 |
| Non deductible health insurer fee | 1.8 |
| | 6.9 |
| | 1.1 |
| Sale of subsidiary | — |
| | (8.0 | ) | | — |
| Other | (0.1 | ) | | (1.4 | ) | | 0.9 |
| Effective income tax rate: | 33.4 | % | | 29.6 | % | | 36.7 | % |
| | (a) | Results for all years primarily include tax benefit associated with the earnings of certain non-U.S. subsidiaries that are deemed reinvested indefinitely and the realization of foreign tax credits for certain other subsidiaries. In addition, 2016 reflects a benefit of 2.2% and 2015 reflects a 6.5% benefit related to a Latin American reorganization, while 2014 reflects a benefit of 2.6% related to the conversion of Canadian branch operations of certain U.S. companies to foreign corporate entities. |
|
Summary Of Unrecognized Tax Benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2016, 2015 and 2014 is as follows: | | | | | | | | | | | | | | Years Ended December 31, | | 2016 | | 2015 | | 2014 | Balance at beginning of year | $ | (37,010 | ) | | $ | (6,262 | ) | | $ | (10,322 | ) | Additions based on tax positions related to the current year | (1,021 | ) | | (30,712 | ) | | (2,940 | ) | Reductions based on tax positions related to the current year | — |
| | 102 |
| | 581 |
| Additions for tax positions of prior years | (1,401 | ) | | (2,128 | ) | | (1,037 | ) | Reductions for tax positions of prior years | 3,786 |
| | 431 |
| | 2,495 |
| Lapses | 1,486 |
| | 1,559 |
| | — |
| Settlements | — |
| | — |
| | 4,961 |
| Balance at end of year | $ | (34,160 | ) | | $ | (37,010 | ) | | $ | (6,262 | ) |
|
Summary Of Deferred Tax Assets And Deferred Tax Liabilities | The tax effects of temporary differences that result in significant deferred tax assets and deferred tax liabilities are as follows: | | | | | | | | | | December 31, | | 2016 | | 2015 | Deferred Tax Assets | | | | Policyholder and separate account reserves | $ | 571,675 |
| | $ | 568,053 |
| Accrued liabilities | 39,297 |
| | 32,257 |
| Investments, net | 102,568 |
| | 140,785 |
| Net operating loss carryforwards | 31,735 |
| | 40,479 |
| Deferred gain on disposal of businesses | 81,247 |
| | 32,362 |
| Compensation related | 37,841 |
| | 28,289 |
| Employee and post-retirement benefits | 58,480 |
| | 115,904 |
| Unearned fee income | 48,444 |
| | 50,931 |
| Other | 78,595 |
| | 48,548 |
| Total deferred tax asset | 1,049,882 |
| | 1,057,608 |
| Less valuation allowance | (12,529 | ) | | (13,218 | ) | Deferred tax assets, net of valuation allowance | 1,037,353 |
| | 1,044,390 |
| Deferred Tax Liabilities | | | | Deferred acquisition costs | (984,324 | ) | | (931,630 | ) | Net unrealized appreciation on securities | (243,810 | ) | | (262,075 | ) | Total deferred tax liability | (1,228,134 | ) | | (1,193,705 | ) | Net deferred income tax liability | $ | (190,781 | ) | | $ | (149,315 | ) |
|
Summary Of Net Operating Loss Carryforwards | At December 31, 2016, the Company had $123,304 of net operating loss carryforwards (corresponding to $31,735 deferred tax assets) in certain foreign jurisdictions that will expire if unused as follows: | | | | | Expiration Year | Amount | 2017 - 2021 | $ | 28,116 |
| 2022 - 2026 | 7,450 |
| 2027 - 2031 | 1,199 |
| 2032 - 2036 | 9,407 |
| Unlimited | 77,132 |
| | $ | 123,304 |
|
|